Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
6,828 | Dovepress* | 4,352 | 1,274+ | 909 | 5,626 |
PubMed Central* | 0 | 1,202 | 240 | 1,202 | |
Totals | 4,352 | 2,476 | 1,149 | 6,828 | |
*Since 22 August 2018 +Since July 2016 |
View citations on PubMed Central and Google Scholar